Datavault AI amends DataMeds deal to expand healthcare data license
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
July 29, 2026 9:05 AM EDTDatavault AI extends data monetization and real-world asset tokenization technologies into the DataMeds AIs EinsteinRX Platform
Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data
PHILADELPHIA--(BUSINESS WIRE)-- Datavault AI Inc. (Datavault AI or the Company) (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (RWA) tokenization technologies, today announced that it has amended its definitive agreement with DataMeds AI, Inc. (NASDAQ: MEDS) (DataMEDS) to expand its PharmacyChain... More



